Boston scientific announces agreement to acquire baylis medical company inc.

Marlborough, mass., oct. 6, 2021 /prnewswire/ -- boston scientific corporation (nyse: bsx) today announced that it has entered into a definitive agreement to acquire baylis medical company inc. for an upfront payment of $1.75 billion, subject to closing adjustments.
BSX Ratings Summary
BSX Quant Ranking